{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:46:33Z","timestamp":1778010393749,"version":"3.51.4"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The present review provides a summary of the literature on recent development of new neuromuscular blocking agents and presents clinically well established and new reversal agents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Anesthesiologists are still waiting for the ideal neuromuscular blocking agent with a succinylcholine-like rapid onset and offset without side effects. Recent drug development led to a new series of neuromuscular compounds, called the chlorofumarates such as gantacurium, CW002, and CW011. These drugs have a promising pharmacodynamic profile; importantly, they can rapidly be reversed by L-cysteine adduction without relevant side effects. In addition, a new spectrum of reversal agents are currently examined in preclinical studies: adamgammadex sodium, a modified \u03b3-cyclodextrin derivate that forms an inactive tight inclusion complex with rocuronium or vecuronium and calabadions, capable of reversing both benzylisoquinolines and steroidal neuromuscular blocking agents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Although the recent advancements in neuromuscular research are very promising, to date, the presented drugs are currently not available for clinical use. Clinical studies will determine the role of these developments in anesthesia practice. Therefore, well established combinations such as rocuronium-sugammadex are popular in clinical practice to offer quick paralysis for intubation and to optimize surgical conditions, while providing a fast neuromuscular recovery at the end of surgery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000000891","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T13:18:53Z","timestamp":1593523133000},"page":"490-498","source":"Crossref","is-referenced-by-count":25,"title":["The future of neuromuscular blocking agents"],"prefix":"10.1097","volume":"33","author":[{"given":"Christiane G.","family":"St\u00e4uble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Blobner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"R1-20230827","first-page":"144","article-title":"The use of curare in an aesthesia and for other clinical purposes","volume":"50","author":"Griffith","year":"1944","journal-title":"Can Med Assoc J"},{"key":"R2-20230827","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.1966.03110240071026","article-title":"Controlled relaxation. II. Clinical management of muscle-relaxant administration","volume":"198","author":"De Jong","year":"1966","journal-title":"JAMA"},{"key":"R3-20230827","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00000542-200305000-00005","article-title":"Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial","volume":"98","author":"Mencke","year":"2003","journal-title":"Anesthesiology"},{"key":"R4-20230827","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00464-014-3711-7","article-title":"Neuromuscular blockade improves surgical conditions (NISCO)","volume":"29","author":"Blobner","year":"2015","journal-title":"Surg Endosc"},{"key":"R5-20230827","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00000542-197906000-00014","article-title":"Residual curarization in the recovery room","volume":"50","author":"Viby-Mogensen","year":"1979","journal-title":"Anesthesiology"},{"key":"R6-20230827","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-2044.2001.01921.x","article-title":"Postoperative residual block after intermediate-acting neuromuscular blocking drugs","volume":"56","author":"Hayes","year":"2001","journal-title":"Anaesthesia"},{"key":"R7-20230827","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/00000542-200305000-00004","article-title":"Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action","volume":"98","author":"Debaene","year":"2003","journal-title":"Anesthesiology"},{"key":"R8-20230827","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00000542-199711000-00005","article-title":"Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers","volume":"87","author":"Eriksson","year":"1997","journal-title":"Anesthesiology"},{"key":"R9-20230827","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/00000542-200306000-00006","article-title":"Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade","volume":"98","author":"Eikermann","year":"2003","journal-title":"Anesthesiology"},{"key":"R10-20230827","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1399-6576.1997.tb04851.x","article-title":"Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium","volume":"41","author":"Berg","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"R11-20230827","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(18)30294-7","article-title":"Postanaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study","volume":"7","author":"Kirmeier","year":"2019","journal-title":"Lancet Respir Med"},{"key":"R12-20230827","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000542-197503000-00002","article-title":"Does clinical anesthesia need new neuromuscular blocking agents?","volume":"42","author":"Savarese","year":"1975","journal-title":"Anesthesiology"},{"key":"R13-20230827","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/ALN.0b013e3181dc1b5b","article-title":"Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011","volume":"113","author":"Savarese","year":"2010","journal-title":"Anesthesiology"},{"key":"R14-20230827","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/EJA.0000000000000741","article-title":"Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: a systematic review","volume":"35","author":"Tajaate","year":"2018","journal-title":"Eur J Anaesthesiol"},{"key":"R15-20230827","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40140-018-0262-9","article-title":"New drug developments for neuromuscular blockade and reversal: gantacurium, CW002, CW011, and calabadion","volume":"8","author":"de Boer","year":"2018","journal-title":"Curr Anesthesiol Rep"},{"key":"R16-20230827","doi-asserted-by":"crossref","first-page":"105134","DOI":"10.1016\/j.ejps.2019.105134","article-title":"Safety, tolerability, and pharmacokinetics of adamgammadex sodium, a novel agent to reverse the action of rocuronium and vecuronium, in healthy volunteers","volume":"141","author":"Jiang","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"R17-20230827","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/bja\/aex318","article-title":"Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation","volume":"119","author":"Hunter","year":"2017","journal-title":"Br J Anaesth"},{"key":"R18-20230827","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00000542-200404000-00013","article-title":"Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium","volume":"100","author":"Savarese","year":"2004","journal-title":"Anesthesiology"},{"key":"R19-20230827","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1021\/jm990060j","article-title":"Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting nondepolarizing neuromuscular blockers","volume":"42","author":"Boros","year":"1999","journal-title":"J Med Chem"},{"key":"R20-20230827","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1021\/ol9911573","article-title":"Synthesis of ultra-short-acting neuromuscular blocker GW 0430: a remarkably stereo- and regioselective synthesis of mixed tetrahydroisoquinolinium chlorofumarates","volume":"1","author":"Samano","year":"1999","journal-title":"Org Lett"},{"key":"R21-20230827","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00000542-200404000-00004","article-title":"Clinical pharmacology of GW280430A in humans","volume":"100","author":"Belmont","year":"2004","journal-title":"Anesthesiology"},{"key":"R22-20230827","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00101-017-0289-1","article-title":"Update on muscle relaxation: what comes after succinylcholine, rocuronium and sugammadex?","volume":"66","author":"Zoremba","year":"2017","journal-title":"Anaesthesist"},{"key":"R23-20230827","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/jm020574+","article-title":"Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys","volume":"46","author":"Boros","year":"2003","journal-title":"J Med Chem"},{"key":"R24-20230827","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/bja\/aep093","article-title":"Reversal of neuromuscular block","volume":"103","author":"Srivastava","year":"2009","journal-title":"Br J Anaesth"},{"key":"R25-20230827","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/ALN.0b013e3181d31f71","article-title":"Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs","volume":"112","author":"Heerdt","year":"2010","journal-title":"Anesthesiology"},{"key":"R26-20230827","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/ALN.0b013e3181d31f8c","article-title":"Cysteine reversal of the novel neuromuscular blocking drug CW002 in dogs: pharmacodynamics, acute cardiovascular effects, and preliminary toxicology","volume":"112","author":"Sunaga","year":"2010","journal-title":"Anesthesiology"},{"key":"R27-20230827","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/ALN.0000000000001386","article-title":"Dose-response and cardiopulmonary side effects of the novel neuromuscular-blocking drug CW002 in man","volume":"125","author":"Heerdt","year":"2016","journal-title":"Anesthesiology"},{"key":"R28-20230827","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1213\/ANE.0b013e3181da8312","article-title":"Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness","volume":"111","author":"Brull","year":"2010","journal-title":"Anesth Analg"},{"key":"R29-20230827","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1213\/01.ane.0000260135.46070.c3","article-title":"A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block","volume":"104","author":"Groudine","year":"2007","journal-title":"Anesth Analg"},{"key":"R30-20230827","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1213\/01.ane.0000248224.42707.48","article-title":"Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine","volume":"104","author":"Sacan","year":"2007","journal-title":"Anesth Analg"},{"key":"R31-20230827","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.redar.2014.02.005","article-title":"Sugammadex and anaphylaxis in the operating theater","volume":"61","author":"Baldo","year":"2014","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"R32-20230827","first-page":"57","article-title":"Sugammadex as a reversal agent for neuromuscular block: an evidence-based review","volume":"8","author":"Schaller","year":"2013","journal-title":"Core evidence"},{"key":"R33-20230827","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcrc.2008.10.010","article-title":"Preclinical pharmacology of sugammadex","volume":"24","author":"Bom","year":"2009","journal-title":"J Crit Care"},{"key":"R34-20230827","first-page":"746","article-title":"Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment","volume":"55","author":"Min","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R35-20230827","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/EJA.0000000000000312","article-title":"Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: a comparative prospective clinical trial","volume":"32","author":"de Souza","year":"2015","journal-title":"Eur J Anaesthesiol"},{"key":"R36-20230827","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.anes.0000270722.95764.37","article-title":"Reversal of rocuronium-induced (1.2\u200amg\/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study","volume":"107","author":"de Boer","year":"2007","journal-title":"Anesthesiology"},{"key":"R37-20230827","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1213\/ANE.0b013e3181c3be3c","article-title":"A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia","volume":"110","author":"Duvaldestin","year":"2010","journal-title":"Anesth Analg"},{"key":"R38-20230827","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/ALN.0b013e31818a3fee","article-title":"Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine","volume":"109","author":"Jones","year":"2008","journal-title":"Anesthesiology"},{"key":"R39-20230827","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00000542-200702000-00016","article-title":"Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent","volume":"106","author":"Suy","year":"2007","journal-title":"Anesthesiology"},{"key":"R40-20230827","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ALN.0b013e318194caaa","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients","volume":"110","author":"Plaud","year":"2009","journal-title":"Anesthesiology"},{"key":"R41-20230827","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00000542-200604000-00009","article-title":"Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study","volume":"104","author":"Sorgenfrei","year":"2006","journal-title":"Anesthesiology"},{"key":"R42-20230827","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1213\/01.ane.0000231829.29177.8e","article-title":"Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane","volume":"104","author":"Vanacker","year":"2007","journal-title":"Anesth Analg"},{"key":"R43-20230827","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/ALN.0b013e318297ce95","article-title":"Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation","volume":"119","author":"Pongracz","year":"2013","journal-title":"Anesthesiology"},{"key":"R44-20230827","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3181f4182a","article-title":"Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block","volume":"113","author":"Schaller","year":"2010","journal-title":"Anesthesiology"},{"key":"R45-20230827","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/EJA.0b013e32833d56b7","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial","volume":"27","author":"Blobner","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"R46-20230827","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/bja\/aev437","article-title":"Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)dagger","volume":"116","author":"Kaufhold","year":"2016","journal-title":"Br J Anaesth"},{"key":"R47-20230827","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1213\/01.ane.0000244594.63318.fc","article-title":"Sugammadex: another milestone in clinical neuromuscular pharmacology","volume":"104","author":"Naguib","year":"2007","journal-title":"Anesth Analg"},{"key":"R49-20230827","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/anae.12736","article-title":"Hypersensitivity associated with sugammadex administration: a systematic review","volume":"69","author":"Tsur","year":"2014","journal-title":"Anaesthesia"},{"key":"R50-20230827","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00540-015-2105-x","article-title":"Sugammadex and rocuronium-induced anaphylaxis","volume":"30","author":"Takazawa","year":"2016","journal-title":"J Anesth"},{"key":"R51-20230827","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2253-14-92","article-title":"Three suspected cases of sugammadex-induced anaphylactic shock","volume":"14","author":"Takazawa","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"R52-20230827","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4097\/kjae.2013.65.6.495","article-title":"Sugammadex: clinical development and practical use","volume":"65","author":"Fuchs-Buder","year":"2013","journal-title":"Kor J Anesthesiol"},{"key":"R53-20230827","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/ACO.0000000000000209","article-title":"Novel neuromuscular blocking drugs and antagonists","volume":"28","author":"Heerdt","year":"2015","journal-title":"Curr Opin Anaesthesiol"},{"key":"R54-20230827","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ALN.0b013e3182910213","article-title":"Calabadion: A new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents","volume":"119","author":"Hoffmann","year":"2013","journal-title":"Anesthesiology"},{"key":"R55-20230827","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/ALN.0000000000000868","article-title":"Comparative effectiveness of calabadion and sugammadex to reverse nondepolarizing neuromuscular-blocking agents","volume":"123","author":"Haerter","year":"2015","journal-title":"Anesthesiology"},{"key":"R56-20230827","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1039\/C3OB42603C","article-title":"Acyclic CB[n]-type molecular containers: effect of solubilizing group on their function as solubilizing excipients","volume":"12","author":"Zhang","year":"2014","journal-title":"Org Biomol Chem"},{"key":"R57-20230827","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1055\/s-0029-1224784","article-title":"Sugammadex--a new era in the antagonsim of muscle relaxants","volume":"44","author":"Rex","year":"2009","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000000891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T03:47:53Z","timestamp":1693108073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000000891","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]}}}